Effect of 5-HT2-selective agonists on cat platelet aggregation

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• Platelet aggregation plays a crucial role in hemostasis and thrombosis.
• Serotonin (5-HT) is known to influence platelet function.
• The 5-HT2 receptor subtype is implicated in various physiological processes.

Purpose of the Study:

• To investigate the effects of 5-HT2-selective agonists, DOB and DOI, on cat platelet aggregation.
• To compare the activity of DOB and DOI with serotonin (5-HT) and a positional isomer (isoDOB).
• To elucidate the role of 5-HT2 receptors in serotonin-induced platelet aggregation.

Main Methods:

• Cat platelet-rich plasma was used for aggregation studies.
• Platelet aggregation was induced by adenosine diphosphate (ADP).
• The effects of serotonin (5-HT), DOB, DOI, and isoDOB were assessed.
• The role of 5-HT2 receptors was evaluated using the selective antagonist ketanserin.

Main Results:

• Serotonin (5-HT), DOB, and DOI significantly enhanced ADP-induced platelet aggregation.
• The inactive isomer, isoDOB, did not affect platelet aggregation.
• Pre-incubation with ketanserin completely inhibited the aggregation-enhancing effects of 5-HT, DOB, and DOI.

Conclusions:

• The 5-HT2 receptor mediates the enhancement of cat platelet aggregation induced by serotonin and its selective agonists.
• DOB and DOI are potent agonists for 5-HT2 receptors involved in platelet function.
• These findings support the involvement of 5-HT2 receptors in serotonin-mediated platelet activation.